BridgeBio Oncology Therapeutics's total assets for Q3 2025 were $484.79M, an increase of 220.52% from the previous quarter. BBOT total liabilities were $38.09M for the fiscal quarter, a -89.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.